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Two-dimensional gel electrophoretic analysis of cell lysates from Brucella abortus 2308 and the isogenic hfq
mutant Hfq3 revealed that the RNA binding protein Hfq (also known as host factor I or HF-I) is required for
the optimal stationary phase production of the periplasmic Cu,Zn superoxide dismutase SodC. An isogenic
sodC mutant, designated MEK2, was constructed from B. abortus 2308 by gene replacement, and the sodC
mutant exhibited much greater susceptibility to killing by O2
 generated by pyrogallol and the xanthine
oxidase reaction than the parental 2308 strain supporting a role for SodC in protecting this bacterium from
O2
 of exogenous origin. The B. abortus sodC mutant was also found to be much more sensitive to killing by
cultured resident peritoneal macrophages from C57BL6J mice than 2308, and the attenuation displayed by
MEK2 in cultured murine macrophages was enhanced when these phagocytes were treated with gamma
interferon (IFN-). The attenuation displayed by the B. abortus sodC mutant in both resting and IFN--
activated macrophages was alleviated, however, when these host cells were treated with the NADPH oxidase
inhibitor apocynin. Consistent with its increased susceptibility to killing by cultured murine macrophages, the
B. abortus sodC mutant also displayed significant attenuation in experimentally infected C57BL6J mice
compared to the parental strain. These experimental findings indicate that SodC protects B. abortus 2308 from
the respiratory burst of host macrophages. They also suggest that reduced SodC levels may contribute to the
attenuation displayed by the B. abortus hfq mutant Hfq3 in the mouse model.
The Brucella spp. are gram-negative facultative intracellular
pathogens capable of infecting a wide variety of mammalian
hosts. Brucella abortus is the etiological agent of bovine bru-
cellosis, an infection that leads to spontaneous abortion and
infertility (10). Human brucellosis presents as a debilitating
febrile illness commonly referred to as Malta Fever or undu-
lant fever (59), and an active infection is characterized by fever,
malaise, chills, night sweats, and anorexia. Human brucellosis
is a zoonotic disease; therefore, the incidence of disease in
humans is directly related to its occurrence in animals (43).
Although considered mainly an occupational hazard in many
countries, human brucellosis remains a significant problem
where the disease is endemic in food animals and raw milk or
other unpasteurized dairy products are still consumed.
Brucella spp. are not found free living, nor are they com-
mensal organisms (23). The preferred ecological niche for the
brucellae is within the phagosomal compartment of host mac-
rophages, and the capacity of this organism to establish and
maintain chronic infections is dependent upon its ability to
survive and replicate within these phagocytic cells (48). Exper-
imental evidence indicates that the production of reactive ox-
ygen intermediates (ROIs) represents one of the primary
mechanisms utilized by host macrophages for limiting the in-
tracellular replication of the brucellae. For instance, detoxifiers
of the superoxide anion (e.g., superoxide dismutase) and hy-
drogen peroxide (e.g., catalase) dampen the brucellacidal ef-
fects of cultured macrophages (30). Conversely, treatment of
cultured macrophages with the electron-accepting compound
methylene blue, which increases macrophage ROI production,
decreases the number of surviving intracellular brucellae in
these phagocytes. Remarkably, although opsonization of the
brucellae with immunoglobulin G (IgG) or activation of mac-
rophages with gamma interferon (IFN-), factors that are
known to increase ROI production, enhances the brucellacidal
activity of these phagocytes, virulent strains of Brucella still
resist killing by these host cells and demonstrate net intracel-
lular replication (16, 29). Accordingly, the brucellae appear to
be well equipped to deal with the exposure to ROIs they
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encounter during their intracellular residence in host macro-
phages (32, 48).
Genetic and biochemical studies have identified an antioxi-
dant that would appear to be ideally suited to protect the
brucellae from the respiratory burst of host macrophages, the
periplasmic Cu,Zn cofactored superoxide dismutase (SOD)
encoded by sodC (4, 8). The SODs are a family of metalloen-
zymes containing either iron, manganese, or copper and zinc at
their active sites (5, 31, 58). These enzymes catalyze the dis-
mutation of superoxide (O2
) to hydrogen peroxide (H2O2)
(37, 38), which can then be further detoxified through the
action of catalases and peroxidases. Most aerobic bacteria con-
tain either a Mn or Fe cofactored SOD in their cytoplasm that
serves to detoxify endogenous superoxide arising as a by-prod-
uct of aerobic metabolism (19). Once thought to be strictly a
eukaryotic enzyme, the function of Cu,Zn SOD in bacteria is
not as clearly understood as its cytosolic counterparts (34).
Superoxide is a weakly anionic species, (39), and is not thought
to cross the cytoplasmic membrane (26). In fact, experimental
evidence indicates that bacterial SODs only detoxify O2
 in
the intracellular compartment within which they reside (51).
The inability of O2
 to cross the cytoplasmic membrane, cou-
pled with the periplasmic location of SodC, has led to the
proposal that SodC most likely protects bacteria from super-
oxide of exogenous origin (54). For bacterial pathogens such as
Brucella that survive and replicate in host macrophages, one
obvious source of exogenous O2
 would be exposure to the
respiratory burst of host phagocytes. Indeed, genetic evidence
suggests that SodC homologs play important roles in protect-
ing Salmonella enterica serovar Typhimurium, Neisseria menin-
gitidis, and Mycobacterium tuberculosis from oxidative killing by
host macrophages (11, 12, 44). Previous studies, however, have
left the role of SodC in protecting Brucella from the oxidative
killing of host macrophages unresolved (35, 55).
In this study we report conclusive data demonstrating the
role of the B. abortus Cu,Zn SOD (SodC) in protecting these
cells from oxidative killing in vitro and in conferring resistance
to the actions of the respiratory burst of host-derived macro-
phages ex vivo. We also present evidence supporting a regula-
tory link between the RNA binding protein Hfq and optimal
stationary-phase sodC expression in B. abortus 2308 and dis-
cuss the possible implications that inefficient SodC production
might have on the phenotype displayed by the B. abortus hfq
mutant Hfq3 (46).
MATERIALS AND METHODS
Bacterial strains, media, and growth conditions. The bacterial strains and
plasmids used in this study are listed in Table 1. Routine cultivation of Esche-
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Genotype or description Reference or source
Strains
Escherichia coli DH5- F 80dlacZM15(lacZYA-argF)U169 deoR recA1 endA1 hsdR17 phoA
supE441-thi-1 gyrA96 relA1
Gibco-BRL
Brucella abortus
2308 Virulent challenge strain Laboratory stock
Hfq3 2308 hfq::aphA 46
MEK2 2308 sodC::cat This study
MEK2Cm MEK2 carrying pJG22 This study
MEK2Cm* MEK2 carrying pMEK15 This study
Plasmids
pUC9 Cloning vector; ColE-1 origin of replication; ampicillin resistance Gibco-BRL
pUC18 Cloning vector; ColE-1 origin of replication; ampicillin resistance Gibco-BRL
pBluescriptII KS Cloning vector; ColE-1 origin of replication; ampicillin resistance Stratagene
pBBR1MCS-4 Cloning vector; broad-host range; moderate copy number (10 copies per
cell); ampicillin resistance
33
pMR10 Cloning vector; broad-host range; low copy number (2 to 4 copies per cell);
kanamycin resistance
NCBI accession
no. AJ606312
pBlue-Cm2 945-bp PCR amplified cat gene from pBC-SK cloned into pBluescriptII KS 47
pBA23 3.2-kb Sau3A fragment containing sodC cloned into the BamHI site of pUC9 35
pBA23.10 2-kb HindIII/EcoRV fragment containing sodC cloned into pBluescriptII KS This study
pBA23.10::cat Derivative of pBA23.10 in which a 226-bp SmaI/NaeI fragment internal to the
sodC coding region has been replaced with the cat gene from pBlue Cm2
This study
pMEK15 2-kb EcoRV/HindIII fragment containing sodC cloned into pBBR1MCS-4 This study
pJG22 2-kb EcoRI/XhoI fragment containing sodC cloned into pMR10 This study
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richia coli strains was carried out in Luria-Bertani (LB) broth or on tryptic soy
agar (TSA) plates with appropriate antibiotic supplementation as necessary.
Brucella abortus strains were routinely grown in either brucella broth at 37°C with
aeration, on Schaedler agar supplemented with 5% bovine blood (SBA) at 37°C
under 5% CO2, or on Schaedler agar supplemented with 1,000 U/ml of bovine
liver catalase (Sigma) as indicated in the text. Gerhardt’s minimal medium
(GMM) was prepared as previously described (21). Culture media were supple-
mented with 100 g/ml ampicillin, 5 g/ml chloramphenicol, or 45 g/ml kana-
mycin when appropriate. Frozen stocks of the bacteria were maintained at
80°C in 25% glycerol–75% brucella broth.
Preparation of bacterial cell lysates for two-dimensional gel electrophoresis.
B. abortus 2308 and Hfq3 were grown for 96 h in GMM. Bacterial cells were
harvested by centrifugation and washed three times with 10 mM Tris HCl, pH
8.0, and then suspended in sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) sample buffer (0.3% SDS, 0.2 M dithiothreitol, 0.05 M
Tris HCl, pH 8.0). After boiling for 10 min to ensure loss of viability, the cells
were lysed by sonication. The sonicated suspension was boiled for an additional
10 min and then placed on ice. The suspension was treated with DNase I and
RNase A at final concentrations of 0.1 mg/ml and 0.025 mg/ml, respectively, for
20 min on ice. Protein concentrations were determined using the Coomassie Plus
Protein Assay Reagent (Pierce).
Two-dimensional gel electrophoresis. Fifty to 200 g of total protein was
diluted to 400 l with thiourea buffer, which contained 5 M urea, 2 M thiourea,
2% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate, 2% SB 3-10
(Bio-Rad), 40 mM Tris, 0.2% Bio-lyte 3/10, 2 mM tributyl phosphine, and was
allowed to rehydrate with an Immobiline Drystrip, pH 4 to 7 (Amersham Phar-
macia), overnight under oil. Isoelectric focusing was carried out in an IPG
pHaser (Genomic Solutions) according to the manufacturer’s instructions. After
focusing, the immobilized pH gradient strip was equilibrated in equilibration
buffer (6 M urea, 2% dithiothreitol, 30% glycerol, 5% SDS, 0.112 M Tris-acetate,
and 0.01% bromophenol blue) for 15 min. A second equilibration was carried out
in the same solution, except dithiothreitol was replaced with 2.5% iodoacetamide
for another 15 min. After equilibration, the strip was sealed on top of a precast
10% Duracryl-Tris/Tricine/SDS gel (Genomic Solutions) using 0.5% low-melting
agarose dissolved in cathode running buffer (0.2 M Tris, 0.2 M Tricine, and 0.4%
SDS). Second-dimension separation of proteins was performed in the Investiga-
tor 2D Electrophoresis System (Genomic Solutions) following the manufactur-
er’s instructions.
After electrophoresis, the resolved protein spots were either stained using the
Protein Silver Staining kit (Amersham Pharmacia) with glutaraldehyde removed
from the sensitization step or transferred to polyvinylidene difluoride (PVDF)
membranes (Hyperbond; Porton Instruments) without prior staining. Images of
the gels were captured with the Investigator Proteomic Analyzer Camera System
(Genomic Solutions) and analyzed by Investigator HT Proteomic Analysis Soft-
ware (Genomic Solutions). Identities of protein spots were determined by ma-
trix-assisted laser desorption ionization–time-of-flight peptide mass fingerprint-
ing or N-terminal sequence analysis.
N-terminal protein sequence analysis. To obtain N-terminal amino acid se-
quence data on selected proteins, proteins resolved in two dimensions were
transferred to PVDF membranes by the semiwet transfer method (Investigator
Graphite Electroblotter System; Genomic Solutions). The membranes were then
stained with Coomassie brilliant blue according to previously described proce-
dures (56, 57). The desired protein spots were cut out based on comparisons to
similarly run silver stained gels and subjected to microsequence analysis using an
automated sequencer. Searches for sequence identity or homology were per-
formed using the FASTA program. The blastp algorithm was used to compare
the N-terminal amino acid sequence data obtained with the predicted products
of the open reading frames annotated in the B. melitensis and B. suis genome
sequences (http://www.ncbi.nlm.gov/genomes/MICROBES/Complete.html).
Construction of a Brucella abortus sodC mutant. Cloning, subcloning, and
isolation of plasmid DNA from recombinant E. coli strains were performed using
standard procedures (52). A previously described gene replacement strategy (24)
was used to construct a B. abortus sodC mutant from virulent strain 2308 in the
following manner. A 226-bp SmaI/NaeI fragment internal to the sodC coding
region in pBA23 (Table 1) was replaced with a 945-bp PCR-generated fragment
containing the cat gene from pBlue-CM2 (47). The resulting plasmid, designated
pBA23.10sodC::cat, was introduced into B. abortus 2308 by electroporation as
described previously (14), and one transformant was selected based upon its
resistance to chloramphenicol and sensitivity to ampicillin. This transformant
was assigned the designation MEK2 (Table 1). Genomic DNA isolation was
isolated from B. abortus MEK2 using the methods of Pitcher et al. (45), and the
predicted genotype of this mutant was verified by Southern blot analysis with
sodC-, cat-, and vector-specific probes (data not shown).
To facilitate genetic complementation of the B. abortus sodC mutant, low- and
medium-copy plasmids bearing intact copies of sodC were constructed. A 2-kb
EcoRV/HindIII fragment containing the sodC gene from pBA23 was first cloned
into the medium-copy plasmid pBBR1MCS-4 (33) to yield plasmid pMEK15
(Table 1). A 2.0-kb EcoRI/XhoI-digested fragment containing the sodC gene
from pMEK15 was also subsequently cloned into the low-copy RK2-based plas-
mid pMR10 (GenBank accession no. AJ606312), producing pJG22. These sodC-
containing plasmids were introduced into B. abortus MEK2 by electroporation
yielding strains designated MEK2Cm [MEK2 (pJG22)] and MEK2Cm* [MEK2
(pMEK15)].
Resistance of Brucella abortus strains to H2O2 and the O2
 generating com-
pound pyrogallol in a disk sensitivity assay. Brucella abortus 2308, MEK2, and
MEK2Cm* were grown to mid-log phase in brucella broth, and the cultures were
adjusted to an optical density at 600 nm of 0.15 (approximately 109 CFU/ml).
One-hundred l of each cell suspension was spread onto Schaedler agar (SA) for
the H2O2 sensitivity assays or SA supplemented with 1,000 U/ml of bovine liver
catalase (Sigma) for the pyrogallol sensitivity assay. A 7-mm-diameter Whatman
filter paper disk was placed in the center of each plate and impregnated with 10
l of one of the following solutions: 970 mM H2O2, 9.7 M H2O2, or 1 M
pyrogallol. After approximately 3 days of incubation at 37°C with 5% CO2, the
diameter of the zone of inhibition surrounding each disk on the plates was
measured to the nearest millimeter. The diameters of the zones of inhibition
from five separate plates were measured for each strain examined.
Resistance of B. abortus strains to exogenous O2
 generated by the xanthine
oxidase reaction. Brucella abortus 2308, MEK2, and MEK2Cm were grown to
mid-log phase in brucella broth, harvested by centrifugation, washed twice in
phosphate-buffered saline (PBS), and adjusted to a density of approximately 5 	
107 cells per ml in PBS. Xanthine at a final concentration of 1,000 M and 0.5
U/ml of xanthine oxidase were added to these cell suspensions along with 1,000
U/ml of bovine liver catalase to detoxify any H202 generated by spontaneous
dismutation of the O2 generated by the xanthine oxidase reaction. At selected
time points after initiating the xanthine oxidase reaction, the number of surviving
bacteria in the cell suspensions was determined by 10-fold serial dilution and
plating on SA supplemented with 1,000 U/ml of bovine liver catalase. Plates were
incubated for approximately 3 days at 37°C with 5% CO2, and the results from
three independent platings of each bacterial cell suspension were calculated and
averaged, and the data obtained were expressed as log10 CFU/ml at each sam-
pling time.
Survival and replication of the Brucella abortus strains in cultured murine
macrophages. Previously described procedures (15) were used to harvest and
infect cultured murine resident peritoneal macrophages with B. abortus 2308,
MEK2, and MEK2Cm. Briefly, 6- to 8-week old female C57BL6J mice were
euthanized by isoflurane overdose. Immediately following euthanasia, cells from
the peritoneal cavity were harvested via lavage using 8 ml of Dulbecco’s minimal
essential medium (DMEM) supplemented with 5% fetal calf serum (FCS) and 5
U/ml heparin. Total cell numbers and viability were determined using a hema-
cytometer and the trypan blue exclusion technique. Explanted cells were then
seeded at a density of 1.5 	 105 cells per well in sterile 96-well microtiter plates
in DMEM supplemented with 5% FCS and 5 g/ml gentamicin.
After overnight incubation at 37°C in 5% CO2, cell cultures were enriched for
macrophages by washing away nonadherent cells. Cultured macrophages were
then infected with either 2308, MEK2, or MEK2Cm opsonized for 30 min with
a subagglutinating dilution (1:1,500) of hyperimmune C57BL6J mouse serum at
a multiplicity of infection (MOI) of 50 brucellae per macrophage (MOI of 50:1)
and incubated at 37°C with 5% CO2 for 2 h to allow for phagocytosis of the
brucellae. After this 2-h period, cell culture medium was removed and replaced
with DMEM supplemented with 5% FCS and 50 g/ml of gentamicin, and
incubation at 37°C with 5% CO2 continued for 1 h to kill any remaining extra-
cellular brucellae. The macrophages were then washed with PBS supplemented
with 0.5% FCS and maintained thereafter in DMEM with 5% FCS and 12.5
g/ml of gentamicin. Cell culture medium was replaced with fresh medium every
24 h. At 3, 27, and 51 h after infection, macrophages were washed with PBS
supplemented with 0.5% FCS and lysed with 0.1% deoxycholic acid in PBS. After
5 min of incubation at room temperature, serial 10-fold dilutions of the lysates
were prepared in sterile PBS and plated on SBA. Platings were performed in
triplicate from 3 wells per strain at each time point, and the data obtained were
expressed as log10 intracellular brucellae. Host cell lysates were also plated on
SBA supplemented with 5 g/ml of chloramphenicol and/or SBA containing a
combination of 5 g/ml chloramphenicol and 45 g/ml kanamycin to confirm the
identity of reisolates and monitor the stability of the plasmid in MEK2Cm.
Parallel experiments were also performed to examine the effects of treatment
of the cultured macrophages with (i) IFN-; (ii) the NADPH oxidase inhibitor
apocynin (25); or (iii) a combination of IFN- and apocynin on the capacity of
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these phagocytes to kill the intracellular brucellae. Twenty-five U/ml of IFN-
(Roche) and/or 500 M (final concentration) of apocynin were added to each
treated well of phagocytes immediately after plating. Apocynin was also added to
treated wells again 6 h prior to infection with the brucellae. Microscopic analysis
of nitroblue tetrazolium reduction was used to monitor the oxidative burst
capacity of the cultured macrophages (7), and control experiments were per-
formed to ensure that apocynin at this concentration had no brucellacidal effect
in DMEM (data not shown).
Experimental infection of C57BL6J mice. Brucella strains were grown on SBA
with or without antibiotics as appropriate, and infection doses were prepared as
described previously (14). Briefly, 6- to 8-week old female C57BL6J mice were
infected via the intraperitoneal route with approximately 5 	 104 brucellae. At 1,
4, and 8 weeks postinfection, 5 mice per experimental group were sacrificed by
isoflurane overdose. Immediately following euthanasia, spleens were harvested
aseptically and homogenized in sterile PBS. Spleen homogenates were then
serially diluted 10-fold in sterile PBS and plated onto SBA to determine the
number of brucellae present at each time point. Spleen homogenates were also
plated in parallel on SBA supplemented with the appropriate antibiotics to
confirm the identity of the isolates and monitor the stability of the plasmid in
MEK2Cm. Mean averages of counts from each test group were determined, and
the data were expressed as log10 brucellae/spleen.
Statistical analysis. All statistical analyses were performed using the Student’s
two-tailed t test. P values  0.05 were considered significant (50).
RESULTS
Hfq is required for the optimal production of SodC during
stationary phase in B. abortus 2308. Previous studies in our
laboratory have shown that the B. abortus hfq mutant Hfq3
exhibits increased susceptibility to a variety of environmental
stresses (including exposure to ROIs) during stationary phase,
and this phenotype is most pronounced when this mutant is
cultivated in a defined minimal medium (46). Interestingly,
two-dimensional gel electrophoretic analysis of cell lysates
from B. abortus 2308 and the isogenic hfq mutant Hfq3 cultures
grown to stationary phase in GMM shows that wild-type pro-
duction of SodC by B. abortus 2308 is dependent upon the
presence of Hfq (49) (Fig. 1). This observation suggests that
inefficient sodC expression may make a significant contribution
to the ROI sensitivity displayed by the B. abortus hfq mutant
Hfq3 and possibly the attenuation displayed by this mutant in
experimentally infected mice (46).
The B. abortus sodC mutant is sensitive to exogenous super-
oxide. Based upon the proposed function and periplasmic lo-
cation of SodC, we predicted that a B. abortus sodC mutant
would be defective in its ability to resist exposure to exogenous
superoxide. To evaluate the sensitivity of MEK2 (sodC::cat; see
Table 1) to superoxide, we performed disk diffusion assays with
the compound pyrogallol (1,2,3-trihydroxybenzene), whose
spontaneous auto oxidation results in the generation of the
superoxide anion (36). Because O2
 production by pyrogallol
does not require a reaction between this compound and the
metabolic intermediates NADH or NADPH, O2
 is generated
in the extracellular environment of cells exposed to pyrogallol.
The B. abortus sodC mutant MEK2 was significantly more
sensitive to pyrogallol than the parental strain 2308 in the disk
sensitivity assay (Fig. 2A), and resistance to exogenous super-
oxide could be restored to a level equivalent to that exhibited
by 2308 by introducing a plasmid-borne copy of sodC into
MEK2. In contrast, 2308 and MEK2 were found to be equally
resistant to H2O2 exposure in the disk diffusion assays (Fig.
2B).
Although increased sensitivity to pyrogallol is a characteris-
tic phenotype exhibited by bacterial sodC mutants (53), disk
assays represent a chronic exposure to O2
 stress that is de-
pendent upon the diffusion of the compound into the plating
medium over time. Considering the short half-life of O2
 as
well as its propensity to spontaneously dismute to H2O2, we
wanted a more definitive assessment of the sensitivity of the B.
abortus sodC mutant to exogenous O2
. Therefore, we per-
formed a second assay using the xanthine oxidase reaction to
generate exogenous superoxide (11). Xanthine oxidase con-
verts xanthine to urate, and O2
 is generated during the course
of this reaction (18). Xanthine oxidase is too large to cross cell
membranes, and consequently the xanthine oxidase reaction
has been widely used as a method for generating O2
 in the
extracellular environment of both prokaryotic and eukaryotic
cells. Following a 1-h exposure to the xanthine oxidase reac-
tion, survival of the B. abortus sodC mutant MEK2 was reduced
approximately 100-fold compared to that displayed by the pa-
FIG. 1. Hfq is required for the wild-type expression of sodC in B. abortus 2308. Panels represent corresponding segments from silver-stained
polyacrylamide gels following two-dimensional gel electrophoretic analysis of cell lysates from cultures of B. abortus 2308 and the isogenic hfq
mutant Hfq3 grown for 96 h in Gerhardt’s minimal medium. Protein spots corresponding to GroES (which is produced at equivalent levels in B.
abortus 2308 and Hfq3 under these cultural conditions) and HdeA (the product of another gene requiring Hfq for its efficient stationary-phase
expression in B. abortus 2308 [49]) are shown as a basis for comparison. SodC, HdeA, and GroES were identified by matrix-assisted laser desorption
ionization–time-of-flight peptide mass fingerprinting and/or N-terminal amino acid sequence analysis as described in Materials and Methods.
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rental 2308 strain (Fig. 3), and introduction of a plasmid-borne
copy of sodC into MEK2 restored the resistance of this mutant
to the xanthine oxidase reaction to wild-type levels (Fig. 3).
SodC is required for wild-type survival and replication of
Brucella abortus 2308 in cultured murine macrophages. In
keeping with the demonstrated sensitivity of MEK2 to expo-
sure to exogenous O2
 in vitro, we predicted that this mutant
might be defective in its capacity to replicate within cultured
murine macrophages due to an inability to detoxify the O2

generated by the respiratory burst of these phagocytes. Con-
sistent with this prediction, the B. abortus sodC mutant MEK2
displayed a significant reduction in its capacity to resist killing
by cultured murine macrophages compared to 2308, as evi-
denced by the reduced number of intracellular MEK2 versus
2308 being recovered from the cultured murine macrophages
at all three sampling times postinfection (Fig. 4A), and the
attenuation exhibited by MEK2 compared to 2308 in the cul-
tured murine macrophages was enhanced when these phago-
cytes were treated with IFN- prior to infection (Fig. 4B). The
attenuation displayed by MEK2 compared to 2308 in both
nonactivated and IFN- activated macrophages, however, was
reduced considerably when the host cells were treated with the
NADPH oxidase inhibitor apocynin (Fig. 4C and D). These
experimental findings indicate that the respiratory burst of the
cultured murine macrophages contributes significantly to the
attenuation displayed by the B. abortus sodC mutant in these
phagocytes. MEK2Cm, a derivative of MEK2 carrying sodC on
FIG. 2. Resistance of B. abortus 2308 (white bars), MEK2 (2308 sodC) (black bars), and MEK2Cm* [MEK2 (pMEK15)] (hatched bars) to
killing by (A) pyrogallol or (B) H2O2 in a disk sensitivity assay. Error bars represent the standard deviations taken from the averages of five zones
per strain. Significance values: the double asterisk indicates P  0.01 for comparisons of MEK2 versus 2308 and MEK2Cm*.
FIG. 3. Resistance of B. abortus 2308 (‚), MEK2 (2308 sodC) (■),
and MEK2Cm [MEK2 (pJG22)] () to killing by O2
 generated by
the xanthine oxidase reaction. The error bars represent standard de-
viations in average log10 CFU/ml values obtained from triplicate plat-
ings taken at each time point. Significance values: **, P  0.01; ***, P
 0.005 for comparisons of MEK2 versus 2308 and MEK2Cm.
FIG. 4. Intracellular survival and replication of B. abortus 2308 (‚),
MEK2 (2308 sodC) (■), and MEK2Cm [MEK2 (pJG22)] () in pri-
mary cultures of resident peritoneal macrophages from C57BL6J mice.
A) untreated macrophages; B) macrophages treated with 25 U/ml per
well of IFN-; C) macrophages treated with 500 M apocynin; D)
macrophages treated with 25 U/ml of IFN- and 500 M apocynin.
The error bars represent standard deviation in average log10 intracel-
lular brucellae from triplicate platings taken at each time point. Sig-
nificance values: *, P  0.05; and **, P  0.01 for comparisons of
MEK2 versus 2308 and MEK2Cm.
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a pMR10-based plasmid, displayed a level of resistance to
killing by the cultured murine macrophages that was not sta-
tistically different from that exhibited by B. abortus 2308 under
all of the experimental conditions employed (Fig. 4A to D).
These results verify the link between the sodC mutation in
MEK2 and the increased sensitivity of this mutant to the oxi-
dative killing pathways of the cultured murine macrophages.
More importantly, these findings coupled with those obtained
with the NADPH oxidase inhibitor apocynin are consistent
with SodC functioning as an antioxidant that protects B. abor-
tus 2308 from exposure to O2
 generated by the respiratory
burst of host phagocytes.
SodC is essential for the establishment and maintenance of
chronic infection in experimentally infected mice. To test
whether the reduced intracellular survival observed for the
sodC mutant in explanted nonactivated or IFN--activated
macrophages would translate into reduced virulence in an ex-
perimental host, the spleen colonization profiles of B. abortus
2308, MEK2, and MEK2Cm in C57BL6J mice were deter-
mined. The B. abortus sodC mutant MEK2 displayed signifi-
cant attenuation compared to 2308 at 1, 4, and 8 weeks postin-
fection in C57BL6J mice (Fig. 5). MEK2Cm, the MEK2
derivative carrying sodC on the pMR10-based plasmid pJG22,
displayed a spleen colonization profile in mice that was inter-
mediate between that displayed by B. abortus 2308 and MEK2
at 1 week postinfection. However, the numbers of B. abortus
2308 and MEK2 recovered from the spleens of mice infected
with these strains were not statistically different at 4 and 8
weeks postinfection. These experimental findings not only es-
tablish a correlation between the increased susceptibility of the
B. abortus sodC mutant to killing by macrophages and attenu-
ation in mice, but they also support the link between the sodC
mutation in MEK2 and the phenotype displayed by this mutant
in the mouse model from a genetic standpoint.
DISCUSSION
The experimental findings described in this report establish
SodC as an antioxidant that protects B. abortus 2308 from O2

of exogenous origin. More importantly, from the perspective of
the intracellular lifestyle of the brucellae, the phenotype dis-
played by the B. abortus sodC mutant MEK2 during its inter-
actions with cultured murine macrophages suggests that SodC
protects the parent strain from O2
 generated by the respira-
tory burst of host macrophages. IFN- activation of host mac-
rophages leads to the increased production of ROIs by these
phagocytes (6, 42). This relationship is consistent with our
findings that differential killing of 2308 and MEK2 was en-
hanced in cultured murine macrophages activated with IFN-
compared to the differences in killing observed for these
strains in nonactivated macrophages. A positive correlation
between ROI production and the enhanced killing activity of
the IFN- activated macrophages for the B. abortus sodC mu-
tant was further supported by the finding that apocynin treat-
ment reduced the attenuation displayed by MEK2 in IFN--
activated phagocytes, allowing this strain to display net
intracellular replication in these cells between 27 and 51 h
postinfection. Interestingly, apocynin treatment failed to to-
tally alleviate the attenuation displayed by the B. abortus sodC
mutant in the cultured murine macrophages. One possibility
for this experimental finding is that the concentration of apo-
cynin used in these experiments did not completely inhibit the
respiratory burst of these cultured phagocytes. Another possi-
bility is that the B. abortus sodC mutant possesses a defect in its
ability to resist the microbicidal activities of host macrophages
that is unrelated or indirectly related to the reduced capacity of
this strain to defend itself against the oxidative burst of these
phagocytes. Regardless, the results of these studies demon-
strate that the B. abortus SodC performs a similar function to
that ascribed to its counterparts in Salmonella (11) and Myco-
bacterium tuberculosis (44) and protects this bacterium from
O2
 generated by the oxidative burst of host macrophages.
Mutants of B. abortus that exhibit defects in their ability to
survive and replicate within macrophages are generally atten-
uated in the mouse model of chronic infection (2, 3), and this
relationship held true when the virulence of the B. abortus
sodC mutant MEK2 in C57BL6J mice was compared to that
displayed by the virulent parent strain. Notably, the attenua-
tion displayed by MEK2 in mice appears to be biphasic. At 1
week postinfection, the numbers of MEK2 recovered from the
spleens of experimentally infected mice was considerably lower
than the inoculum, while in contrast the numbers of the parent
strain recovered from the spleens of infected mice increased
fivefold compared to the inoculum during this same period.
These contrasting phenotypes are consistent with the B. abor-
tus sodC mutant being much more sensitive to the ROI burst
during internalization into resting or nonactivated macro-
phages during the early stages of infection than the virulent
parental strain. Between 1 and 4 weeks postinfection, however,
the number of MEK2 recovered from the spleens of infected
mice appears to stabilize. This phenotype is also consistent
with our finding that once the B. abortus sodC mutant is inter-
nalized into nonactivated macrophages, it can survive and rep-
licate within these phagocytes. The second phase of attenua-
tion displayed by MEK2 in mice begins at some point beyond
FIG. 5. Spleen colonization profiles of B. abortus 2308 (‚), MEK2
(2308 sodC) (■), and MEK2Cm (MEK2pJG22) () in C57BL6J mice.
The error bars represent the standard deviation in the average of the
number of brucellae recovered from the spleens of five mice per strain
at each time point. Significance values: *, P  0.05; and **, P  0.01
for comparisons between 2308 and MEK2; †, P  0.05; and ††, P 
0.01 for comparisons between MEK2 and MEK2Cm.
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4 weeks postinfection. Specifically, between 4 and 8 weeks
postinfection, the B. abortus sodC mutant displays accelerated
clearance from the spleens of C57BL6J mice compared to the
parent strain 2308. This is the period during which previous
studies have shown that cellular immunity is induced in mice
experimentally infected with B. abortus (1), which would lead
to an increased number of IFN--activated macrophages being
present. Consequently, accelerated clearance of MEK2 from
the spleens of experimentally infected mice beginning at 4
weeks postinfection or shortly thereafter would be consistent
with the increased susceptibility of the B. abortus sodC mutant
to killing by IFN- activated macrophages compared to the
parental strain observed in the host cell culture assays.
Previous studies evaluating the virulence of B. abortus sodC
mutants in experimentally infected mice generated conflicting
results. Latimer et al. (35), for instance, reported no differ-
ences between the spleen colonization profiles of B. abortus
2308 and an isogenic sodC mutant at 1 and 4 weeks postinfec-
tion when these strains were evaluated in BALB/c mice. Tatum
et al. (55), on the other hand, found significant differences in
the spleen colonization profiles of B. abortus 2308 and an
isogenic sodC mutant throughout the course of a 16-week
infection, with the sodC mutant displaying significant attenua-
tion compared to 2308 at most of the experimental time points
examined. These latter authors also reported observing no
significant differences between the intracellular survival and
replication patterns of B. abortus 2308 and the sodC mutant in
HeLa cells or in the murine macrophage-like cell line J774
(55). The reasons underlying the discrepancies between these
earlier reports and the studies presented here are unknown. It
is quite possible, however, that the macrophages isolated from
the peritoneal cavities of the C57BL6J mice produce a more
robust oxidative burst in primary culture than the J774 and
HeLa cell lines, and this could explain the differential behavior
of the B. abortus sodC mutants in these different host cell types.
It has also been reported that BALB/c mice experience an
interruption in IFN- production during infection with Bru-
cella strains that is not observed in C57BL6J mice (41). Con-
sidering the well-documented link between IFN- activation,
ROI production, and the brucellacidal activity of murine mac-
rophages (29, 30), it is also quite possible that the B. abortus
sodC mutant experiences a less intense exposure to O2
 of
phagocyte origin during its residence in BALB/c mice than it
does during its residence in C57BL6J mice.
The nature of the regulatory link between Hfq and station-
ary phase sodC expression in B. abortus 2308 is presently under
investigation. Bacterial sodC genes are typically regulated in a
growth-phase-dependent manner, and their expression is usu-
ally maximal during stationary phase (22, 53). In enteric bac-
teria such as Escherichia coli and Salmonella enterica serovar
Typhimurium, Hfq is an RNA binding protein that facilitates
efficient translation of the rpoS transcript coincident with entry
into stationary phase (9, 40). RpoS is an alternate stationary-
phase-specific sigma factor (
S), and increased levels of RpoS
lead to the increased expression of a number of different gene
products involved in resistance to a variety of environmental
stresses upon entry into stationary phase (13, 27, 28). In E. coli
and S. enterica serovar Typhimurium, RpoS, and consequently
Hfq, are responsible for increased expression of sodC during
stationary phase (17, 22). Based on recent experimental find-
ings with the sodB gene of E. coli (20), the possibility also exists
that Hfq plays a direct role in regulating sodC expression in B.
abortus 2308 at the posttranscriptional level. The B. abortus hfq
mutant Hfq3 displays increased sensitivity to O2
 in in vitro
assays compared to the parental 2308 strain (J. Gee, unpub-
lished observations), and this mutant is also highly attenuated
in both cultured murine macrophages and experimentally in-
fected mice (44). The phenotype displayed by the B. abortus
sodC mutant MEK2 certainly suggests that inefficient sodC
expression might play a role in the generalized ROI sensitivity
displayed by the B. abortus hfq mutant Hfq3 in vitro and po-
tentially contributes to the extreme attenuation displayed by
this mutant in the mouse model. It is important to note, how-
ever, that experiments to date suggest that greater than 40 B.
abortus 2308 genes require Hfq for their efficient expression
during stationary phase (49), and experimental analysis of
other Hfq regulated genes has determined that inefficient sodC
expression is not the sole basis for the attenuation displayed by
the B. abortus hfq mutant in experimentally infected mice
(M. W. Valderas, R. B. Alcantara, J. B. Baumgartner, J. M.
Gee, and R. M. Roop II, Abstr. 103rd Gen. Meet. Am. Soc.
Microbiol., abstr. E-065, 2003) (48).
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